OGN
NYSE · Pharmaceuticals
Organon & Co
$13.43
+0.01 (+0.07%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+87.05%
1Y
+37.04%
YTD
+85.50%
Open$13.44
Previous Close$13.42
Day High$13.44
Day Low$13.40
52W High$13.49
52W Low$5.69
Volume—
Avg Volume2.70M
Market Cap3.53B
P/E Ratio14.34
EPS$0.94
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$7.87
Above
SMA 200
$8.85
Above
RSI (14)
32.1
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Sell
13 analysts
Price Target
+573.1% upside
Current
$13.43
$13.43
Target
$90.40
$90.40
$73.92
$90.40 avg
$125.40
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.26B | 6.24B | 515.23M |
| Net Income | 188.18M | 168.97M | 144.40M |
| Profit Margin | 3.0% | 2.9% | 28.0% |
| EBITDA | 584.68M | 554.18M | 186.20M |
| Free Cash Flow | — | — | 113.95M |
| Rev Growth | +0.2% | +0.2% | +11.5% |
| Debt/Equity | 11.49 | 11.49 | 0.71 |
Dividend
Dividend Yield0.60%
Annual Dividend$0.34
Payout Ratio47.1%
Frequencyquarterly
Ex-DividendMar 29, 2026
Pay DateApr 18, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |